|Bid||201.00 x 100|
|Ask||219.93 x 100|
|Day's range||214.50 - 216.08|
|52-week range||119.37 - 216.08|
|PE ratio (TTM)||43.11|
|Earnings date||29 Jan 2018 - 2 Feb 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||220.40|
Illumina, Inc. today announced that its executives will be speaking at the following investor conference, and invites investors to participate via webcast.
Illumina, Inc. announced today that the High Court of Justice, Chancery Division, Patents Court in the United Kingdom issued a judgment in its favor in the patent infringement suit filed against Premaitha Health plc, et al.
SAN DIEGO--(BUSINESSWIRE)-- Illumina, Inc. (NASDAQ: ILMN) announced today that the High Court of Justice, Chancery Division, Patents Court in the United Kingdom issued a judgment in its favor in the patent ...
Illumina (ILMN) expands NGS platform. The company has a solid diagnostic NGS portfolio, which includes NextSeq 550Dx and MiSeqDx.
Illumina, Inc. announced today the introduction of its NextSeq™ 550Dx instrument, the company’s second FDA-regulated and CE-IVD marked next-generation sequencing system.
Healthcare won't be the same in the future because of these pioneers in gene editing, gene sequencing, and artificial intelligence.
Illumina, Inc. announced today that Gary S. Guthart will join the company’s Board of Directors on December 1, 2017. Dr. Guthart is President and Chief Executive Officer of Intuitive Surgical, a global leader in the field of robotic-assisted minimally invasive surgery.
The gene-sequencing leader posted strong revenue and earnings growth in the third quarter -- and upped its full-year guidance, too.
The San Diego-based company said it had profit of $1.11 per share. The results surpassed Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings ...
Illumina Ventures, which launched with a $100 million commitment from Illumina Inc. last year, said it has closed a $230 million debut life sciences fund and has made seven deals.
Illumina, Inc. today announced the availability of the NovaSeq S4 flow cell, reagent kit and NovaSeq Xp workflow for its NovaSeq™ 6000 System. Flow cell innovation is key to unlocking the power and flexibility of the NovaSeq platform and the release of this new flow cell and workflow extends the capabilities of the platform to empower high intensity sequencing across a wide range of sequencing methods....
Illumina rides high on product launches, including the latest release of VeriSeq NIPT in Europe, and strong uptake of NovaSeq. Weak margins remain a concern.
Illumina, Inc. today announced that it will issue results for third quarter 2017 following the close of market on Tuesday, October 24, 2017.
Companies that make lab equipment, testing supplies and analytical devices have driven the sector up 41 percent, beating the much-discussed internet giants
SAN DIEGO--(BUSINESSWIRE)-- Illumina, Inc. (NASDAQ:ILMN) announced today that the company has filed a new patent infringement suit against Premaitha Health plc in the High Court of Justice, Chancery Division, ...
Karius has figured out a way to separate out disease-causing agents from bacteria that live harmoniously in the body. It just raised $50 million.